Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 140

Related Citations for PubMed (Select 24305552)

1.

Musashi2 predicts poor prognosis and invasion in hepatocellular carcinoma by driving epithelial-mesenchymal transition.

He L, Zhou X, Qu C, Hu L, Tang Y, Zhang Q, Liang M, Hong J.

J Cell Mol Med. 2014 Jan;18(1):49-58. doi: 10.1111/jcmm.12158. Epub 2013 Oct 31.

2.

Embryonic morphogen nodal is associated with progression and poor prognosis of hepatocellular carcinoma.

Chen J, Liu WB, Jia WD, Xu GL, Ma JL, Ren Y, Chen H, Sun SN, Huang M, Li JS.

PLoS One. 2014 Jan 21;9(1):e85840. doi: 10.1371/journal.pone.0085840. eCollection 2014.

3.

Expression and prognostic significance of golgiglycoprotein73 (GP73) with epithelial-mesenchymal transition (EMT) related molecules in hepatocellular carcinoma (HCC).

Bao YX, Cao Q, Yang Y, Mao R, Xiao L, Zhang H, Zhao HR, Wen H.

Diagn Pathol. 2013 Dec 6;8:197. doi: 10.1186/1746-1596-8-197.

4.

Down-regulated KLF17 expression is associated with tumor invasion and poor prognosis in hepatocellular carcinoma.

Liu FY, Deng YL, Li Y, Zeng D, Zhou ZZ, Tian DA, Liu M.

Med Oncol. 2013 Mar;30(1):425. doi: 10.1007/s12032-012-0425-3. Epub 2013 Jan 17.

PMID:
23325444
5.

As an independent prognostic factor, FAT10 promotes hepatitis B virus-related hepatocellular carcinoma progression via Akt/GSK3β pathway.

Liu L, Dong Z, Liang J, Cao C, Sun J, Ding Y, Wu D.

Oncogene. 2014 Feb 13;33(7):909-20. doi: 10.1038/onc.2013.236. Epub 2013 Jul 1.

PMID:
23812429
6.

SIN1 promotes invasion and metastasis of hepatocellular carcinoma by facilitating epithelial-mesenchymal transition.

Xu J, Li X, Yang H, Chang R, Kong C, Yang L.

Cancer. 2013 Jun 15;119(12):2247-57. doi: 10.1002/cncr.28023. Epub 2013 Apr 5.

7.

Reciprocal activation between ATPase inhibitory factor 1 and NF-κB drives hepatocellular carcinoma angiogenesis and metastasis.

Song R, Song H, Liang Y, Yin D, Zhang H, Zheng T, Wang J, Lu Z, Song X, Pei T, Qin Y, Li Y, Xie C, Sun B, Shi H, Li S, Meng X, Yang G, Pan S, Zhu J, Qi S, Jiang H, Zhang Z, Liu L.

Hepatology. 2014 Nov;60(5):1659-73. doi: 10.1002/hep.27312. Epub 2014 Oct 2.

PMID:
25042864
8.
9.

BVES inhibition triggers epithelial-mesenchymal transition in human hepatocellular carcinoma.

Han P, Fu Y, Luo M, He J, Liu J, Liao J, Tian D, Yan W.

Dig Dis Sci. 2014 May;59(5):992-1000. doi: 10.1007/s10620-013-2992-3. Epub 2014 Jan 18.

PMID:
24442236
10.

Promotion of hepatocellular carcinoma metastasis through matrix metalloproteinase activation by epithelial-mesenchymal transition regulator Twist1.

Zhao XL, Sun T, Che N, Sun D, Zhao N, Dong XY, Gu Q, Yao Z, Sun BC.

J Cell Mol Med. 2011 Mar;15(3):691-700. doi: 10.1111/j.1582-4934.2010.01052.x.

PMID:
20219012
11.

Hypoxia induces epithelial-mesenchymal transition via activation of SNAI1 by hypoxia-inducible factor -1α in hepatocellular carcinoma.

Zhang L, Huang G, Li X, Zhang Y, Jiang Y, Shen J, Liu J, Wang Q, Zhu J, Feng X, Dong J, Qian C.

BMC Cancer. 2013 Mar 9;13:108. doi: 10.1186/1471-2407-13-108.

12.

Caveolin-1 is up-regulated by GLI1 and contributes to GLI1-driven EMT in hepatocellular carcinoma.

Gai X, Lu Z, Tu K, Liang Z, Zheng X.

PLoS One. 2014 Jan 13;9(1):e84551. doi: 10.1371/journal.pone.0084551. eCollection 2014.

13.

Serglycin (SRGN) overexpression predicts poor prognosis in hepatocellular carcinoma patients.

He L, Zhou X, Qu C, Tang Y, Zhang Q, Hong J.

Med Oncol. 2013 Dec;30(4):707. doi: 10.1007/s12032-013-0707-4. Epub 2013 Aug 31.

PMID:
23996242
14.

The beta2-adrenergic receptor is a potential prognostic biomarker for human hepatocellular carcinoma after curative resection.

Chen D, Xing W, Hong J, Wang M, Huang Y, Zhu C, Yuan Y, Zeng W.

Ann Surg Oncol. 2012 Oct;19(11):3556-65. doi: 10.1245/s10434-012-2396-1. Epub 2012 May 17.

PMID:
22588469
15.

14-3-3ε overexpression contributes to epithelial-mesenchymal transition of hepatocellular carcinoma.

Liu TA, Jan YJ, Ko BS, Liang SM, Chen SC, Wang J, Hsu C, Wu YM, Liou JY.

PLoS One. 2013;8(3):e57968. doi: 10.1371/journal.pone.0057968. Epub 2013 Mar 6.

16.

Lipocalin-2 negatively modulates the epithelial-to-mesenchymal transition in hepatocellular carcinoma through the epidermal growth factor (TGF-beta1)/Lcn2/Twist1 pathway.

Wang YP, Yu GR, Lee MJ, Lee SY, Chu IS, Leem SH, Kim DG.

Hepatology. 2013 Oct;58(4):1349-61. doi: 10.1002/hep.26467. Epub 2013 Aug 7.

PMID:
23696034
17.

Overexpression of forkhead box C1 promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinoma.

Xia L, Huang W, Tian D, Zhu H, Qi X, Chen Z, Zhang Y, Hu H, Fan D, Nie Y, Wu K.

Hepatology. 2013 Feb;57(2):610-24. doi: 10.1002/hep.26029.

PMID:
22911555
19.

Decreased expression of SERPINB1 correlates with tumor invasion and poor prognosis in hepatocellular carcinoma.

Cui X, Liu Y, Wan C, Lu C, Cai J, He S, Ni T, Zhu J, Wei L, Zhang Y, Qian H.

J Mol Histol. 2014 Feb;45(1):59-68. doi: 10.1007/s10735-013-9529-0. Epub 2013 Oct 9.

PMID:
24105272
20.

Reduced N-cadherin expression is associated with metastatic potential and poor surgical outcomes of hepatocellular carcinoma.

Zhan DQ, Wei S, Liu C, Liang BY, Ji GB, Chen XP, Xiong M, Huang ZY.

J Gastroenterol Hepatol. 2012 Jan;27(1):173-80. doi: 10.1111/j.1440-1746.2011.06847.x.

PMID:
21777276
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk